Abstract |
Lymphoma is a clinically and biologically heterogeneous disease. Next-generation sequencing (NGS) has expanded our understanding of this heterogeneity at the genetic level, refining disease classification, defining new entities, and providing additional information that can be used in diagnosis and management. This review highlights some of the NGS findings in lymphoma and how they can be used as genetic biomarkers to aid diagnosis and prognosis and guide therapy.
|
Authors | Graham W Slack |
Journal | Surgical pathology clinics
(Surg Pathol Clin)
Vol. 16
Issue 2
Pg. 433-442
(Jun 2023)
ISSN: 1875-9157 [Electronic] United States |
PMID | 37149368
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2023 Elsevier Inc. All rights reserved. |
Topics |
- Humans
- Mutation
- Prognosis
- Lymphoma
(diagnosis, genetics, pathology)
- High-Throughput Nucleotide Sequencing
|